Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS Prodigy-Reference-Cited by-同舟云学术

Automated manufacturing of chimeric antigen receptor T cells for adoptive immunotherapy using CliniMACS Prodigy

Published:2016-08 Issue:8 Volume:18 Page:1002-1011
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Mock Ulrike,Nickolay Lauren,Philip Brian,Cheung Gordon Weng-Kit,Zhan Hong,Johnston Ian C.D.,Kaiser Andrew D.,Peggs Karl,Pule Martin,Thrasher Adrian J.,Qasim Waseem

Funder

National Institute of Health Research

NIHR Blood and Transplant Research Unit

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference18 articles.

1. T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia;Kalos;Sci Transl Med,2011

2. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;NEJM,2014

3. Chemotherapy-refractory diffuse large B-cell lymphoma and indolent B-cell malignancies can be effectively treated with autologous T cells expressing an anti-CD19 chimeric antigen receptor;Kochenderfer;J Clin Oncol,2015

4. Towards a commercial process for the manufacture of genetically modified T cells for therapy;Kaiser;Cancer Gene Ther,2015

5. Production and first-in-man use of T cells engineered to express a HSVTK-CD34 sort-suicide gene;Zhan;PLoS ONE,2013

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a robotic cluster for automated and scalable cell therapy manufacturing;Cytotherapy;2024-09

2. Ex vivo T cell differentiation in adoptive immunotherapy manufacturing: Critical process parameters and analytical technologies;Biotechnology Advances;2024-08

3. Peptide-enabled ribonucleoprotein delivery for CRISPR engineering (PERC) in primary human immune cells and hematopoietic stem cells;2024-07-16

4. CAR-T cell expansion platforms yield distinct T cell differentiation states;Cytotherapy;2024-07

5. Augmenting the landscape of chimeric antigen receptor T-cell therapy;Expert Review of Anticancer Therapy;2024-06-26